Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

JHS Svendgaard Laboratories Ltd - 532771 - Submission Of Segment Wise Revenue, Results, Assets And Liabilities For Financial Year Ending 31 March, 2021

 Dear Sir, With reference to the captioned subject and SEBI Circular No CIR/CFD/FAC/62/2016 (Revised Formats for Financial Results and Implementation of IND-AS by Listed Entities) dated July 05, 2016 read with Circular No. CIR/CFD/CMD/15/2015 (Format for Publishing Financial Results) dated 30" November,2015, following these circulars, we are hereby submitting our segment reporting disclosure as per IND -AS 108. We also inform you that we have Single segment which includes manufacturing business of oral care products as per our Standalone Financial Statement and Multi-Segment which includes inter-alia manufacturing business, other than manufacturing business and retail business as per our Consolidated Financial Statements for the year ended 31 March, 2021. This is for your kind information and record. Kindly acknowledge the receipt.
22-06-2021
Bigul

JHS SVENDGAARD LABORATORIES LTD. - 532771 - Outcome Of Meeting Of Board Of Directors Held On Tuesday, 22" June,2021

 In accordance with Regulation 30 read with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations, 2015'), we wish to inform your good office that the Board of Directors of JHS Svendgaard Laboratories Limited ('the Company') at their meeting held today i.e. on Tuesday, June 22, 2021 has, inter alia, considered and approved the Audited Financial Results (Standalone and Consolidated) of the Company for the quarter and year ended on March 31, 2021. The meeting of the Board of Directors commenced at 12:54 PM and concluded at 03:15 P.M. A Copy such Results along with Audit Reports thereon are enclosed as Annexure - A, M/s S.N, Dhawan & Co. LLP, Chartered Accountants, the Statutory Auditors of the Company have issued auditors' reports with an unmodified opinion on the financial results. These results are also being made available on the website of the Company at https://www.svendgaard.com.
22-06-2021
Bigul

JHS SVENDGAARD LABORATORIES LTD. - 532771 - Outcome Of Meeting Of Board Of Directors Held On Tuesday, 22" June,2021

 In accordance with Regulation 30 read with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations, 2015'), we wish to inform your good office that the Board of Directors of JHS Svendgaard Laboratories Limited ('the Company') at their meeting held today i.e. on Tuesday, June 22, 2021 has, inter alia, considered and approved the Audited Financial Results (Standalone and Consolidated) of the Company for the quarter and year ended on March 31, 2021. The meeting of the Board of Directors commenced at 12:54 P.M. and concluded at 03:15 P.M. A Copy such Results along with Audit Reports thereon are enclosed as Annexure - A, M/s S.N, Dhawan & Co. LLP, Chartered Accountants, the Statutory Auditors of the Company have issued auditors' reports with an unmodified opinion on the financial results. These results are also being made available on the website of the Company at https://www.svendgaard.com.
22-06-2021
Bigul

JHS Svendgaard Laboratories Ltd - 532771 - Board Meeting Intimation for Intimation Of Board Meeting

 JHS SVENDGAARD LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/06/2021 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, this is to inform you that a meeting of the Board of Directors of JHS Svendgaard Laboratories Limited (the Company) is scheduled to be held on Tuesday, 22nd June, 2021 via video conferencing, inter-alia, to consider and approve the Audited Financial Results (Standalone & Consolidated) of the Company for the quarter & year ended March 31, 2021. In this connection, as per the Company's Code of Practices & Procedures for fair Disclosure of Unpublished Price Sensitive Information pursuant to SEBI (Prohibition of Insider Trading), Regulations, 2015 the Trading window for dealing in securities of the Company will remain closed for all Insiders from April 01, 2021, till 48 hours after the declaration of such financial results (both days inclusive). Further, the copy of the notice is also available on the website of the Company i.e. https://www.svendgaard.com.
14-06-2021
Bigul

JHS Svendgaard Laboratories Ltd - 532771 - Format of Initial Disclosure to be made by an entity identified as a Large Corporate

 Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompayJHS SVENDGAARD LABORATORIES LTD. 2CINL74110HP2004PLC027558 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.67 4Highest Credit Rating during the previous FY NA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: KIRTI MAHESHWARI Designation: COMPANY SECRETARY AND COMPLIANCE OFFICER EmailId: CS@SVENDGAARD.COM Name of the Chief Financial Officer: ASHISH GOEL Designation: CHIEF FINANCIAL OFFICER EmailId: CS@SVENDGAARD.COM Date: 29/04/2021 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.
29-04-2021
Bigul

JHS SVENDGAARD LABORATORIES LTD. - 532771 - Compliance Certificate Under Regulation 40(9) Of The SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015.

 We are hereby submitting the Compliance Certificate under Regulation 40(9) of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 issued by the Practicing Company Secretary for the quarter and half year ended on 31st March, 2021.
16-04-2021
Bigul

JHS Svendgaard Laboratories Ltd - 532771 - Shareholding for the Period Ended March 31, 2021

 JHS Svendgaard Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2021. For more details, kindly Click here
12-04-2021
Bigul

JHS SVENDGAARD LABORATORIES LTD. - 532771 - Compliance Certificate Under Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Half Year Ended On March 31, 2021.

 Please find enclosed Compliance Certificate under Regulation 7(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the half year ended on March 31, 2021 duly signed by the Compliance Officer of the Company and Authorized Representative of Alankit Assignments Limited, the Registrar and Share Transfer Agent of the Company.
12-04-2021
Bigul

JHS SVENDGAARD LABORATORIES LTD. - 532771 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 We hereby submit the confirmation certificate dated 08th April, 2021 received from M/s. Alankit Assignments Limited, Registrar and Share Transfer Agent (RTA) of our Company as per Regulation 74(5) of the Securities and Exchange Board of India (Depository and Participants) Regulations, 2018 for the quarter ended 31st March, 2021.
12-04-2021
Bigul

JHS SVENDGAARD LABORATORIES LTD. - 532771 - Statement Of Investor Complaints For The Quarter Ended March 2021

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- KIRTI MAHESHWARIDesignation :- Company Secretary and Compliance Officer
10-04-2021
Next Page
Close

Let's Open Free Demat Account